Matthew A. Gubens

UCSF Helen Diller Family Comprehensive Cancer Center

ORCID: 0000-0002-6482-1954

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Phase II Multicenter Study”.

Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Phase II Multicenter Study

Journal of Clinical Oncology(2024)10.1200/jco.24.00071

N/A

1.4DataRank · unranked

60 citations

Anatoly Urisman, Matthew A. Gubens, Claire K. Mulvey, Greg M. Allen, Stephen Shiboski +19 more

The Role of Chemotherapy Plus Immune Checkpoint Inhibitors in Oncogenic-Driven NSCLC: A University of California Lung Cancer Consortium Retrospective Study

JTO Clinical and Research Reports(2022)10.1016/j.jtocrr.2022.100427

N/A

0DataRank · unranked

12 citations

Shuai Chen, Joanna B. Eldredge, Shiruyeh Schokrpur, Debory Li, Zhikuan Quan +11 more

American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic Carcinoma

JAMA Oncology(2023)10.1001/jamaoncol.2023.1175

N/A

0DataRank · unranked

10 citations

Andreas Rimner, Arya Amini, Joe Y. Chang, Jessica Donington, Martin J. Edelman +11 more

Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis

medRxiv(2023)10.1101/2023.05.15.23289680

N/A

0DataRank · unranked

4 citations

Rohit Thummalapalli, Michael J. Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam +23 more

Data from Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non–Small Cell Lung Cancer

(2023)10.1158/1078-0432.c.6530652.v1

N/A

0DataRank · unranked

0 citations

Victoria Martucci, Zoe Quandt, Stefan Groha, Megan H. Murray, Christine M. Lovly +16 more

Associations of frailty with overall survival (OS) and functional decline among older adults with non–small-cell lung cancer (NSCLC) receiving chemotherapy, immunotherapy, and/or targeted therapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12040

N/A

0DataRank · unranked

0 citations

Louise C. Walter, Alexander K. Smith, Ying Shi, W. John Boscardin, Harvey Jay Cohen +15 more

Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis

Nature Communications(2024)10.1038/s41467-023-44512-4

N/A

0DataRank · unranked

33 citations

Rohit Thummalapalli, Michael J. Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam +28 more

Appropriate Use Criteria (AUC) for the Management of Non-Small Cell Lung Cancer in a Central/Ultra-Central Location: Guidelines from the American Radium Society

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.09.1386

N/A

0DataRank · unranked

10 citations

Andreas Rimner, Arya Amini, Joe Y. Chang, Stephen G. Chun, Jessica Donington +12 more

Associations of frailty with survival, hospitalization, functional decline, and toxicity among older adults with advanced non-small cell lung cancer

The Oncologist(2024)10.1093/oncolo/oyae349

N/A

0DataRank · unranked

6 citations

W. John Boscardin, Louise C. Walter, Alexander K. Smith, Harvey Jay Cohen, Smith Giri +19 more

Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events

medRxiv(2024)10.1101/2024.06.10.24308518

N/A

0DataRank · unranked

2 citations

Rohit Thummalapalli, Zoe Quandt, Karmugi Balaratnam, Eduardo Cárdenas, Christina J. Falcon +13 more

Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non–Small Cell Lung Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0921

N/A

0DataRank · unranked

87 citations

Victoria Martucci, Zoe Quandt, Stefan Groha, Megan H. Murray, Christine M. Lovly +16 more

Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-011273

N/A

0DataRank · unranked

7 citations

Rohit Thummalapalli, Zoe Quandt, Karmugi Balaratnam, Eduardo Cárdenas, Christina J. Falcon +13 more